LekoskopLekoskop
UK · ES · FR · CS · IT · NL · CH · HR · PL

Medicine recalls, shortages and safety updates in the UK — February 2026

MHRA medicines recalls and defect notifications with batch numbers, Serious Shortage Protocols, new approvals and Drug Safety Update — updated daily, automatically. Last updated: 27 Sep 2026 13:39.

All Recalls and defects2 Serious shortages (SSP)2 New approvals1 Drug Safety Update1
clear

Sources: we track changes based on information published by the MHRA — medicines recalls and defect notifications, Drug Safety Update and approval announcements — and the Serious Shortage Protocols published by the NHS Business Services Authority. The UK is outside the EU, so European Commission decisions are not listed here.

24 Feb 2026Tuesday 24 February 2026

open day ◀ ▶ 2 events · 1 important
A falsified version of Mounjaro (tirzepatide) KwikPen 15mg solution for injection has been found supplied through one online pharmacy in the UK. The falsified product is labelled with batch D873576 an…
What this means, batches, details

Loading…

As with any medicine, the MHRA will keep the safety and effectiveness of imlunestrant tosylate under close review.
What this means, batches, details

Loading…

23 Feb 2026Monday 23 February 2026

open day ◀ ▶ 1 event · 1 important
Class 2 recall · DMRC-38487919 · Sterling Pharmaceuticals Ltd (specials manufacturer MS 32515) · melatonin
Batches: 200ml (05/11/2024), 200ml (12/11/2024), 200ml (04/02/2025), 200ml (21/02/2025), 200ml (22/04/2025), 200ml (27/06/2025), 200ml (02/09/2025), 200ml (05/11/2025), 200ml (14/12/2025), 200ml (05/02/2026)
What this means, batches, details

Loading…

17 Feb 2026Tuesday 17 February 2026

open day ◀ ▶ 1 event · 1 important
Class 3 recall · DMRC- 38379307 · PL: 20011/0076 · Norgine Limited · polyethylene glycol, potassium chloride, sodium hydrogen carbonate, sodium chloride
What this means, batches, details

Loading…

11 Feb 2026Wednesday 11 February 2026

open day ◀ ▶ 2 events · 2 important
Drug Safety Update IXCHIQ Chikungunya vaccine
Following the completion of a safety review and the recommendations of the Commission on Human Medicines (CHM), the IXCHIQ Chikungunya vaccine is no longer indicated for adults over the age of 60 year…
What this means, batches, details

Loading…

Drug Safety Update IXCHIQ Chikungunya vaccine
The Commission on Human Medicines (CHM) has temporarily restricted use of the IXCHIQ Chikungunya vaccine in people aged 65 years and over following very rare fatal reactions reported globally. This is…
What this means, batches, details

Loading…

5 Feb 2026Thursday 5 February 2026

open day ◀ ▶ 1 event · 1 important
Non-arteritic anterior ischemic optic neuropathy (NAION), a condition that can cause sudden deterioration in vision, usually in one eye at a time, has been very rarely reported in association with sem…
What this means, batches, details

Loading…

In total 10 events this month.